Posted: AUG 18, 2008

CSMG Technologies and Live Tissue Connect Subsidiary Will Present at Noble Financial Equity Conference; FDA 510(k) Clearance for LTC Surgical VAD System, Green Energy Business, Growth Strategy to Be Discussed

Investors Can Access Presentation Live Via Internet Tuesday August 19, 12 Noon (PDT)

Corpus Christi, TX, August 18, 2008 -- CSMG Technologies, Inc., (OTCBB: CTGI - News), a technology management company, announced Donald S. Robbins, President and CEO of CSMG Technologies, was invited to present at the Fourth Annual Noble Financial Equity Conference at 12:00 p.m.(Pacific) on Tuesday, August 19, 2008, at the Loews Lake Las Vegas Resort, Nevada.

Mr. Robbins, along with Live Tissue Connect, Inc. (LTC) President Frank D. D'Amelio, will give a comprehensive presentation regarding CSMG Technologies, including its subsidiary company LTC, which last month received US FDA 510(k) clearance to market its LTC VAD System for Duct and Vessel sealing. Additionally, CSMG's Green Energy strategy, including the recent acquisition of Carbon Capture Technologies, will be discussed along will management's strategy to grow revenues of CSMG and LTC.

CSMG Technologies presentation will be webcast live:
Investors may view the presentation via the below Internet link

12:00 p.m. (Pacific), Tuesday, August 19, 2008


http://hosted.mediasite.com/hosted4/Viewer/?peid=5f1f6769-e59f-4b0f-bcd4-af0a1bda8326


Access is available by logging on to the conference website
www.noblemadmax.com

or by going to CSMG Technologies website:
www.csmgtechinternational.com


It is recommended that interested parties register at least 15 minutes prior to the
start of the presentation to ensure timely access.

The LTC VAD System, used in human surgery, consists of a LTC VAD.400 bipolar electrosurgical generator and two disposable sealing instruments. FDA clearance allows LTC to market these products in the United States. LTC will be starting the process of ordering production tooling and piece parts to enable the production assembly process later this year.

The VAD.400 generator and the two disposable instruments are intended for use in open general surgical and gynecological procedures for the ligation of vessels and ducts as an alternative to mechanical clamping (clips or staples) and suturing. LTC’s new third generation bipolar system can be used on vessels (veins and arteries) up to 7 mm diameter, on ducts up to 2 mm diameter, and on tissue bundles as large as will fit in the jaw electrodes of the instruments.

About CSMG Technologies, Inc.

CSMG Technologies, Inc. (OTCBB: CTGI) together with its subsidiaries, operates as a technology management company. The company engages in owning, developing, patenting, managing, licensing, and marketing technologies.

Subsidiary Live Tissue Connect (LTC) provides live biological tissue bonding technology that focuses on bonding living soft biological tissue used in surgical procedures, without the use of sutures, staples, sealants, or glues.

In June 2008, CSMG acquired Carbon Capture Technologies Inc. which owns a worldwide exclusive license to a composition and method for use of a novel Carbon Dioxide (CO2) adsorbent. Researchers at the University of Ottawa developed recyclable CO2 adsorbents based on surface modified nanoporous silicas. The materials show fast and reversible high adsorption capacity, allowing it to be reused repeatedly in a high throughput periodic cyclic adsorption process. The adsorbents can be used in both wet and dry environments, potentially eliminating significant engineering challenges. The potential uses for the technology include capturing the bulk of C02 emissions from coal-fired power plants in order that these greenhouse gasses could be sequestered and thus reduce the carbon footprint of such facilities, as well as surgical and mine rescue applications.

CSMG was incorporated in 1992 and is headquartered in Corpus Christi, Texas.

About Live Tissue Connect

LTC's surgical tissue bonding / welding device is a patented platform technology that bonds and reconnects human soft tissue through fusion, in contrast with conventional wound closing devices such as sutures, staples, sealant, or glues. LTC currently holds a total of approximately 31 patents and pending patents in the U.S., Australia, Canada, European Union, Ukraine and other countries.

For further information on CSMG Technologies and its various subsidiaries, please visit our website at www.csmgtechinternational.com.

Sign up to receive CSMG Technologies automated email press releases and other notifications: Please go to: www.csmgtechinternational.com/contact_information.html and fill-in information.

About Noble Financial

Noble Financial is a privately-held, full-service capital markets firm driven by what is often overlooked by other firms - uncovering the value embedded in the orphaned, undiscovered or misunderstood company. The company focuses on converting market inefficiencies into profit opportunities. Noble Financial supports emerging companies through strategic advice, investment banking, market-making, sales & trading, comprehensive equity research, and the development of institutional support. Noble Financial's equity conferences - 2008 marks their fourth annual - allow for a unique blend of professional and personal interaction among a diverse cross-section of executives. The company has operated for 24 years and has offices in Florida, New York City and Boston.

This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934 as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors.

CONTACT:

CSMG Technologies, Inc.
Donald S. Robbins, 361-887-7546
President and CEO
or
K. Bruce Jones, 770-955-0409